YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
* Lifecore Biomedical (LFCR [https://seekingalpha.com/symbol/LFCR]) on Monday said it has entered into a definitive agreement to be acquired by Webster Equity Partners in a transaction valued at up to $663.7 million, assuming full achievem…
Greenhaven Road Capital, an investment management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The fund achieved an approximate 11% net return in the second quarter, indicating pro…
Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Manager of Investor Relations - Stephanie Diaz President and Chief Executive Officer - Paul Josephs Chief Financial Officer - Ryan Lake Full Conf…
Key Points Interested in Lifecore Biomedical, Inc.? Here are five stocks we like better. Lifecore reaffirmed its 2026 guidance for revenue of $120 million to $125 million and adjusted EBITDA of $20.5 million to $25 million, despite second-…
-- Reaffirms 2026 Guidance -- -- Multiple New Business Wins, Adding Impactful Programs to Pipeline -- -- Cost Reduction and Productivity Enhancements Continue to Strengthen Organization -- Conference Call Today at 8:00am ET CHASKA, Minn.,…
CHASKA, Minn., July 29, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that it will report financ…
Laughing Water Capital, an investment management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The second quarter was exceptionally good for the portfolio, with Class A investment i…
We recently compiled a list of the 12 Best Low-Priced Pharma Stocks to Buy Right Now. Lifecore Biomedical, Inc. (NASDAQ:LFCR) is one of the best low-priced pharma stocks on this list. TheFly reported on June 16 that Barrington increased it…
CHASKA, Minn., May 21, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that the company will parti…
Lifecore Biomedical logo Key Points Management added three commercial site transfer programs in Q1 — including a U.S. aesthetics transfer and two CDMO agreements (one ophthalmic expansion) — and expects these to generate commercial revenue…
Laughing Water Capital, an investment management company, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded here. The Class A investment in Laughing Water Capital returned approximately -4.5% net of al…
-- Site Transfer Agreement for the Manufacture of Commercially Marketed Product -- -- Second Agreement Supports the Expansion of Product Commercially Manufactured at Lifecore to a New Delivery System -- -- Fourth Commercial Site Transfer A…
Lifecore Biomedical logo Key Points Lifecore has completed its transition into a standalone CDMO after divesting its food businesses and now operates primarily from its Chaska, Minnesota site focused on HA fermentation for highly sterile i…
SAN DIEGO, March 16, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Lifecore Biomedical, Inc. The investigation focuses on Lifecore Biomedical executive officers and whether invest…
Lifecore Biomedical logo Key Points Revenue and profitability improved: Q4 revenue rose to $35.7M (up 10%) and seven-month transition revenue was $75.5M (up 20%), while gross margin climbed to 31% and adjusted EBITDA increased to $8.6M for…
* Lifecore Biomedical press release [https://seekingalpha.com/pr/20438291-lifecore-biomedical-reports-financial-results-for-the-fourth-quarter-and-transition-period] (LFCR [https://seekingalpha.com/symbol/LFCR]): Q4 GAAP EPS of -$0.16. * R…
Information technology, industrials and utilities are set to feature prominently in this week’s earnings calendar, with 249 companies scheduled to report. This week’s quant rankings highlight strong momentum among technology and industrial…
CHASKA, Minn., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that the company will part…
PHILADELPHIA, Jan. 30, 2026 (GLOBE NEWSWIRE) -- WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Lifecore Biomedical, Inc. (NASDAQ: LFCR) as a securities fraud class action has now reached a settlem…
PHILADELPHIA, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Ibotta, Inc. (NYSE: IBTA): WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Ibotta, Inc. (NYSE: IBTA). The investigation concerns whether certain offi…
PHILADELPHIA, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Ibotta, Inc. (NYSE: IBTA): WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Ibotta, Inc. (NYSE: IBTA). The investigation concerns whether certain offi…
PHILADELPHIA, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is investigating claims on behalf of shareholders of Ibotta, Inc. (NYSE: IBTA). The investigation concerns whether certain officers and directors…
CHASKA, Minn., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that on January 14, 2026, the Lifecore…
Laughing Water Capital, an investment management company, released its fourth-quarter 2025 investor letter. In the quarter, Laughing Water Capital returned ~6.8%, bringing the full-year returns to ~3.9% net of fees and expenses. In compari…
The S&P 500 Index ($SPX) (SPY) today is down -0.05%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.23%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.28%. March E-mini S&P futures (ESH26) are down -0.04%, and March E-mini Nasd…
The S&P 500 Index ($SPX) (SPY) today is up +0.62%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.10%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +1.16%. March E-mini S&P futures (ESH26) are up +0.59%, and March E-mini Nasdaq fut…
The S&P 500 Index ($SPX) (SPY) today is down -0.05%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.23%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.28%. March E-mini S&P futures (ESH26) are down -0.04%, and March E-mini Nasd…
PHILADELPHIA, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ: CYTK). The investigation concerns whether certain officer…
The S&P 500 Index ($SPX) (SPY) on Wednesday closed down -0.74%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down -0.63%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.84%. March E-mini S&P futures (ESH26) fell -0.71%, and…
PHILADELPHIA, Dec. 31, 2025 (GLOBE NEWSWIRE) -- CarMax, Inc. (NYSE: KMX): Grabar Law Office is investigating claims on behalf of shareholders of CarMax, Inc. (NYSE: KMX). The investigation concerns whether certain officers and directors br…
Lifecore Biomedical, Inc. CHASKA, Minn., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has…
Agreement Calls for Development Services and Tech Transfer in Preparation for Commercial Manufacturing of Injectable Pharmaceutical Product Partner’s Program Size Positions it to Become a Top Five Commercial Customer for Lifecore CHASKA, M…
Greenhaven Road Capital, an investment management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the third quarter, the fund returned approximately -9%, bringing the YTD returns to…
Earnings Call Insights: Lifecore Biomedical, Inc. (LFCR) Q3 2025 MANAGEMENT VIEW * CEO Paul Josephs highlighted, "Lifecore is a differentiated injectable CDMO with a strong foundation in high-grade hyaluronic acid that has served as our en…
Harmony Biosciences Holdings, Inc. (HRMY) came out with quarterly earnings of $0.87 per share, missing the Zacks Consensus Estimate of $0.92 per share. This compares to earnings of $0.79 per share a year ago. These figures are adjusted for…
CHASKA, Minn., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it will report financial results…